FAGR Fagron SA

Fagron publishes annual report 2022

Fagron publishes annual report 2022

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2023 – 8:00 AM CET

Fagron publishes annual report 2022

Fagron, the leading global player in pharmaceutical compounding, today publishes its annual report 2022. Discussion of the annual report and the approval of the financial statements will be put on the agenda of the annual general meeting of shareholders early May.

The annual report is available in the official Dutch version and in English translation on Fagron’s .

Further information

Karen Berg

Global Investor Relations Manager

Tel. 99

About Fagron

Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics and patients in more than 30 countries around the world.

Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

Please open the link below for the press release:



EN
20/03/2023

Underlying

FAGRFagron SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

Oliver Metzger
  • Oliver Metzger
SOP SOPRA STERIA GROUP SA
GXI GERRESHEIMER AG
FAGR FAGRON SA
ATE ALTEN SA
EMMN EMMI AG
MOB MOBILEZONE HOLDING AG
FNTN FREENET AG
ARYN ARYZTA AG
10/09/25 October 9, 2025 1 EN
Robert Jan Vos ... (+2)
  • Robert Jan Vos
  • Usama Tariq
10/09/25 October 9, 2025 1 EN
ING Helpdesk
  • ING Helpdesk
BFIT BASIC-FIT NV
FAGR FAGRON SA ... (+6)

Benelux Morning Notes

Ahold Delhaize: 3Q25 preview - USD headwind to take centre stage. Basic-Fit: 3Q25 results preview, new consensus, we expect strong membership ingrowth. Fagron: 3Q25 growth hiccup in N America, strong organic performance in EMEA, Latam. Lotus Bakeries: UK VAT conflict for Näkd negatively impacts 2024 profitability. Ontex: 3Q25 preview: consensus implies a second profit warning for FY25F. Randstad: Preview 3Q25F results due 22 October; consensus released. Staffing: French revenue impro...

BFIT BASIC-FIT NV
FAGR FAGRON SA
RAND RANDSTAD NV
LOTB LOTUS BAKERIES NV
ONTEX ONTEX GROUP N.V.
AD KONINKLIJKE AHOLD DELHAIZE N.V.
10/09/25 October 9, 2025 1 EN
Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Livio Luyten
  • Thibault Leneeuw
  • Wim Lewi
FAGR FAGRON SA
SOF SOFINA SA
IVA INVENTIVA SA
ENRGY ENERGYVISION
10/09/25 October 9, 2025 1 EN
 PRESS RELEASE
Free
FAGR FAGRON SA

Fagron reports solid third quarter performance with 6.4% revenue growt...

Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 – 7:00 AM CET Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook Fagron, the leading global player in pharmaceutical compounding today publishes its quarterly results for the period ending 30 September 2025. Key Highlights Q3 2025 organic growth at CER1 of 8.5% on a normalized basis2 and 5.7% including the GLP-1 impactRevenue for ...

October 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch